Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

KOHAUS, ASHLEY

NPI: 1043536295 · CINCINNATI, OH 45229 · Student in an Organized Health Care Education/Training Program · NPI assigned 04/13/2010

$153K
Total Medicaid Paid
3,177
Total Claims
2,694
Beneficiaries
19
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 175 $7K
2019 436 $19K
2020 473 $18K
2021 557 $21K
2022 475 $25K
2023 516 $29K
2024 545 $34K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,112 931 $52K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 674 611 $50K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 140 80 $11K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 130 114 $10K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 171 155 $7K
96110 Developmental screening, with scoring and documentation, per standardized instrument 364 328 $7K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 45 42 $4K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 23 23 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 42 31 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 43 29 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 65 63 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 15 12 $1K
96127 63 58 $1K
0071A 17 13 $520.00
99072 111 95 $12.50
91307 34 25 $0.12
1003F 104 60 $0.00
1220F 12 12 $0.00
1036F 12 12 $0.00